NU Skin Enterprises Inc Stock Research

Market Summary

USD34.55-0.05

Market Closed

-0.14%

NUS Alerts

Big fall in Revenue (Y/Y)
Big fall in earnings (Y/Y)

NUS Stock Price

NUS RSI Chart

NUS Valuation

Market Cap

2.0B

Price/Earnings (Trailing)

19.48

Price/Sales (Trailing)

0.92

EV/EBITDA

Price/Free Cashflow

41.64

NUS Price/Sales (Trailing)

NUS Profitability

EBT Margin

4.00%

Return on Equity

11.68%

Return on Assets

5.75%

Free Cashflow Yield

2.4%

NUS Fundamentals

NUS Revenue

Revenue (TTM)

2.1B

Revenue Y/Y

-20.41%

Revenue Q/Q

-7.83%

NUS Earnings

Earnings (TTM)

77.4M

Earnings Y/Y

-70.62%

Earnings Q/Q

-80.12%

Price Action

52 Week Range

29.9647.84

(Low)(High)

Last 7 days

-4.7%

Last 30 days

-12.6%

Last 90 days

-15.5%

Trailing 12 Months

-23.9%

NUS Financial Health

Current Ratio

2.12

Debt/Equity

0.4

Debt/Cashflow

0.51

NUS Investor Care

Shares Dilution (1Y)

0.20%

Diluted EPS (TTM)

1.52

Peers (Alternatives to NU Skin Enterprises)

View All Peers In Detail

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
PG	357.9B	81.0B	-5.94%	0.62%	25.07	4.46	1.70%	-1.88%
EL	69.6B	15.9B	-19.27%	-18.92%	46.06	4.38	-12.42%	-53.65%
CL	63.2B	18.3B	-0.61%	-1.25%	35.42	3.52	4.93%	-21.82%
KMB	48.5B	20.3B	-5.09%	3.86%	24.55	2.39	2.95%	12.78%
CLX	19.7B	7.2B	-2.66%	10.48%	265.75	2.74	0.89%	-83.84%
MID-CAP
COTY	9.4B	5.4B	-5.40%	65.12%	48.53	1.75	3.31%	-45.41%
BRBR	5.0B	1.5B	4.63%	42.35%	33.6	3.32	14.86%	415.33%
EPC	2.1B	2.2B	-5.61%	12.71%	22.11	0.94	4.71%	-20.28%
SMALL-CAP
NUS	2.0B	2.1B	-12.60%	-23.87%	19.48	0.92	-19.87%	-44.11%
HLF	1.2B	5.1B	-18.14%	-45.86%	4.66	0.23	-9.16%	-36.58%
MED	893.8M	1.6B	-9.97%	-50.57%	6.31	0.56	4.75%	-13.96%
NATR	209.5M	420.1M	4.46%	-10.50%	380.9	0.5	-7.10%	-98.18%
VERU	85.9M	21.3M	-18.75%	-91.77%	-0.62	4.03	-64.80%	-404.09%
NHTC	64.2M	49.4M	-8.16%	-11.41%	179.82	1.22	-14.86%	-18.38%
LFVN	58.2M	210.1M	37.35%	12.32%	-69.16	0.28	-0.04%	-108.92%

Financials for NU Skin Enterprises

* denotes actual numbers (not divided by Millions)
Income Statement (Last 12 Months)					(In Millions)
Description	(%) Q/Q	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1
Revenue	-5.5%	2,102	2,226	2,377	2,480	2,624
Gross Profit	-6.0%	1,499	1,595	1,720	1,838	1,957
Operating Expenses	-4.0%	1,424	1,484	1,616	1,648	1,734
S&GA Expenses	-6.2%	825	880	942	986	1,047
EBITDA	3.9%	161	155	254	294	-
EBITDA Margin	10.9%	0.07*	0.07*	5.02*	0.11*	-
Earnings Before Taxes	-40.6%	53.00	89.00	83.00	180	219
EBT Margin	14.4%	0.04*	0.03*	3.56*	0.08*	-
Net Income	-26.1%	77.00	105	38.00	113	139
Net Income Margin	191.9%	0.05*	0.02*	2.24*	0.05*	-
Free Cahsflow	-61.9%	49.00	129	142	108	-

Balance Sheet					(In Millions)
Description	(%) Q/Q	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1
Assets	0.2%	1,825	1,821	1,763	1,901	1,892
Current Assets	1.8%	774	760	778	883	849
Cash Equivalents	-13.1%	230	265	294	364	302
Inventory	5.9%	367	346	327	354	382
Net PPE	-1.5%	438	445	433	443	449
Goodwill	0%	206	206	206	206	206
Liabilities	0.9%	932	924	921	960	958
Current Liabilities	3.8%	373	359	366	384	494
LT Debt, Current	90.0%	48.00	25.00	43.00	40.00	110
LT Debt, Non Current	-1.3%	373	377	382	387	259
Shareholder's Equity	-0.5%	893	897	842	941	934
Retained Earnings	-0.4%	1,931	1,939	1,901	1,946	1,931
Additional Paid-In Capital	-0.3%	611	613	610	606	599
Shares Outstanding	-0.3%	50.00	50.00	50.00	-	-

Cashflow (Last 12 Months)					(In Millions)
Description	(%) Q/Q	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1
Cashflow From Operations	-27.4%	78.00	108	192	194	168
Share Based Compensation	-1.0%	12.00	12.00	16.00	16.00	21.00
Cashflow From Investing	-6.8%	-71.64	-67.08	-69.27	-61.97	-80.06
Cashflow From Financing	35.3%	-64.36	-99.50	-84.63	-103	-120
Dividend Payments	0.1%	77.00	77.00	77.00	77.00	76.00
Buy Backs	-14.3%	60.00	70.00	70.00	40.00	40.00

Risks for NUS

What is the probability of a big loss on NUS?

81.9%

Probability that NU Skin Enterprises stock will be more than 20% underwater in next one year

70.8%

Probability that NU Skin Enterprises stock will be more than 30% underwater in next one year.

38.1%

Probability that NU Skin Enterprises stock will be more than 40% underwater in next one year.

*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does NUS drawdown profile look like?

Y-axis is the maximum loss one would have experienced if NU Skin Enterprises was unfortunately bought at previous high price.

Drawdowns

Returns for NUS

Cumulative Returns on NUS

-3.0%

10-Year Cumulative Returns

0.5%

7-Year Cumulative Returns

-13.4%

5-Year Cumulative Returns

0.1%

3-Year Cumulative Returns

What are the long-term rolling returns for NUS?

FIve years rolling returns for NU Skin Enterprises.

Annualized Returns

Which funds bought or sold NUS recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
2023-05-23	ROYCE & ASSOCIATES LP	new	-	768,864	768,864	0.01%
2023-05-22	EMC Capital Management	unchanged	-	-14,000	190,000	0.16%
2023-05-22	AMERIPRISE FINANCIAL INC	reduced	-1.35	-747,441	8,566,560	-%
2023-05-18	JPMORGAN CHASE & CO	reduced	-20.2	-2,355,450	6,853,550	-%
2023-05-18	NEW YORK STATE COMMON RETIREMENT FUND	reduced	-27.93	-496,000	1,015,000	-%
2023-05-17	Thrivent Financial for Lutherans	reduced	-3.39	-212,000	1,925,000	-%
2023-05-17	VIRGINIA RETIREMENT SYSTEMS ET AL	reduced	-9.33	130,172	1,024,490	0.01%
2023-05-17	Advisory Services Network, LLC	sold off	-	-	-	-%
2023-05-16	JANE STREET GROUP, LLC	added	75.37	704,074	1,812,540	-%
2023-05-16	Baker Avenue Asset Management, LP	sold off	-100	-211	-	-%

Latest Funds Activity

Are funds buying NUS calls or puts?

Calls

Puts

Are funds bullish or bearish(Calls - Puts)?

Net Call Options

No. of funds that own NUS

No. of Funds

NU Skin Enterprises News

Schedule 13G FIlings of NU Skin Enterprises

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 13, 2023	renaissance technologies llc	4.63%	2,287,596	SC 13G/A
Feb 09, 2023	vanguard group inc	13.13%	6,490,840	SC 13G/A
Feb 09, 2023	state street corp	14.94%	7,384,649	SC 13G/A
Feb 06, 2023	wellington management group llp	7.15%	3,535,969	SC 13G/A
Jan 23, 2023	blackrock inc.	17.0%	8,414,765	SC 13G/A
May 10, 2022	state street corp	17.66%	8,851,823	SC 13G/A
Feb 11, 2022	renaissance technologies llc	5.24%	2,612,396	SC 13G/A
Feb 10, 2022	state street corp	12.61%	6,280,258	SC 13G
Feb 04, 2022	wellington management group llp	8.35%	4,162,517	SC 13G/A
Jan 27, 2022	blackrock inc.	11.6%	5,760,841	SC 13G/A

NUS Fair Value

Recent SEC filings of NU Skin Enterprises

View All Filings

Date Filed	Form Type	Document
May 26, 2023	4	Insider Trading
May 25, 2023	144	Notice of Insider Sale Intent
May 24, 2023	SD	SD
May 15, 2023	144	Notice of Insider Sale Intent
May 09, 2023	144	Notice of Insider Sale Intent
May 09, 2023	4	Insider Trading
May 04, 2023	10-Q	Quarterly Report
May 03, 2023	8-K	Current Report
Apr 25, 2023	4	Insider Trading
Apr 25, 2023	4	Insider Trading

Latest Insider Trading transactions for NUS

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
2023-05-09	WOODBURY EDWINA D	sold	-47,526	37.87	-1,255	-
2023-04-25	LIPMAN ANDREW D	sold	-81,500	40.75	-2,000	-
2023-04-21	Tang Connie Mang Yee	sold (taxes)	-46,334	41.37	-1,120	chief global growth officer
2023-03-31	Thomas James D	acquired	-	-	6,360	interim cfo
2023-03-27	LIPMAN ANDREW D	sold	-78,580	39.29	-2,000	-
2023-03-09	Hatchett Steven Keith	sold	-841,546	39.78	-21,155	chief product officer
2023-03-09	Hatchett Steven Keith	acquired	644,170	30.45	21,155	chief product officer
2023-03-08	WOODBURY EDWINA D	acquired	596	39.74	15.00	-
2023-03-02	CHANG JOSEPH Y	acquired	761,358	30.4543	25,000	chief scientific officer
2023-03-02	CHANG JOSEPH Y	sold	-1,019,250	40.77	-25,000	chief scientific officer

About NU Skin Enterprises

NUS Income Statement

2023-03-31

Consolidated Statements of Income (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Consolidated Statements of Income [Abstract]
Revenue	$ 481,462	$ 604,899
Cost of sales	133,588	161,499
Gross profit	347,874	443,400
Operating expenses:
Selling expenses	188,124	242,699
General and administrative expenses	133,899	148,556
Restructuring and impairment expenses	9,787	0
Total operating expenses	331,810	391,255
Operating income	16,064	52,145
Other income (expense), net	(1,476)	(1,453)
Income before provision for income taxes	14,588	50,692
Provision for income taxes	3,212	11,976
Net income	$ 11,376	$ 38,716
Net income per share (Note 6):
Basic (in dollars per share)	$ 0.23	$ 0.77
Diluted (in dollars per share)	$ 0.23	$ 0.76
Weighted-average common shares outstanding:
Basic (in shares)	49,644	49,991
Diluted (in shares)	50,058	51,066

NUS Balance Sheet

2023-03-31

Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 229,941	$ 264,725
Current investments	16,774	13,784
Accounts receivable, net	60,008	47,360
Inventories, net	366,537	346,183
Prepaid expenses and other	100,302	87,816
Total current assets	773,562	759,868
Property and equipment, net	437,986	444,806
Operating lease right-of-use assets	98,683	98,734
Goodwill	206,432	206,432
Other intangible assets, net	64,711	66,701
Other assets	243,271	244,429
Total assets	1,824,645	1,820,970
Current liabilities:
Accounts payable	49,494	53,963
Accrued expenses	275,774	280,280
Current portion of long-term debt	47,500	25,000
Total current liabilities	372,768	359,243
Operating lease liabilities	78,776	76,540
Long-term debt	372,609	377,466
Other liabilities	107,522	110,425
Total liabilities	931,675	923,674
Commitments and contingencies (Notes 5 and 11)
Stockholders' equity:
Class A common stock - 500 million shares authorized, $0.001 par value, 90.6 million shares issued	91	91
Additional paid-in capital	611,483	613,278
Treasury stock, at cost - 40.7 million and 41.1 million shares	(1,559,080)	(1,569,061)
Accumulated other comprehensive loss	(91,005)	(86,509)
Retained earnings	1,931,481	1,939,497
Total stockholders' equity	892,970	897,296
Total liabilities and stockholders' equity	$ 1,824,645	$ 1,820,970